Italian cohort of Lafora disease: Clinical features, disease evolution, and genotype-phenotype correlations
Antonella Riva(University of Genoa), Pasquale Striano(Great Ormond Street Hospital), V Taramasso(University of Genoa), Francesca Bisulli(Istituto delle Scienze Neurologiche di Bologna), Carlo Minetti(Istituto Giannina Gaslini), Carlo Avolio(University of Foggia), Roberto Michelucci(Istituto delle Scienze Neurologiche di Bologna), Marcello Scala(Hospital for Sick Children), Laura Canafoglia(Fondazione IRCCS Istituto Neurologico Carlo Besta), Cinzia Costa(Diagnostics for the Real World (United States)), Silvana Franceschetti(Fondazione IRCCS Istituto Neurologico Carlo Besta), Elena Di Gennaro(Istituto Giannina Gaslini), Alfredo D’Aniello(Istituto Neurologico Mediterraneo), G. D’Orsi, Maria Tappatà, Federico Zara(Istituto Giannina Gaslini), Alessandro Orsini(University of Pisa), Elena Freri(Fondazione IRCCS Istituto Neurologico Carlo Besta), Edoardo Ferlazzo(Magna Graecia University), Paolo Tinuper(University of Bologna), Pierangelo Veggiotti(University of Pavia), Carla Marini, Giancarlo Di Gennaro(Istituto Neurologico Mediterraneo), Maurizio Elia(Oasi Maria SS), Antonino Romeo(Fatebenefratelli Hospital), Salvatore Striano(Federico II University Hospital), Berge A. Minassian(Southwestern Medical Center), Amedeo Bianchi(Ospedale San Donato), Maria Teresa Di Claudio(Ospedali Riuniti di Foggia), Angela Pistorio(Istituto Giannina Gaslini), Vito Sofia(University of Catania), Adriana Magaudda(Hôpital Sainte-Marguerite)
Cited by 24
Related Papers
Mapping the human genetic architecture of COVID-19
|Nature|2021|1.1k
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Optimal clinical management of children receiving the ketogenic diet: Recommendations of the International Ketogenic Diet Study Group
|Epilepsia|2008|603
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)
|Neurology|1994|407
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences
|Current Neuropharmacology|2018|368